Bengaluru: New England Biolabs (NEB), a global leader in the production of reagents for the life science industry, has announced the opening of its new subsidiary, New England Biolabs India Pvt. Ltd., marking a significant milestone in the company’s international expansion.
The new New England Biolabs office will be located at Phoenix Asia Towers in Bengaluru, Karnataka, India.
The launch of the India subsidiary strengthens New England Biolabs’ global subsidiary network and reinforces the company’s commitment to supporting the rapidly growing life science ecosystem in India.
The country has long been recognized as a global hub for life sciences, driven by strong public sector initiatives and sustained private sector investments.
Also Read: Tenthpin Launches Center for Life Sciences Cloud Solutions in Pune
For many years, New England Biolabs has supported researchers in India through an established distribution network.
With the formation of New England Biolabs India Pvt. Ltd., the company aims to deliver an enhanced level of service to customers and distribution partners across the country.
The new subsidiary is expected to improve accessibility to New England Biolabs products and services while strengthening collaboration with the scientific research community in India.
“This new subsidiary office will provide the scientific research community in India with more efficient access to the latest NEB products and technical support in the local time zone, a state-of-the-art Experience Center and footprint for local manufacturing activities, as well as custom partnership opportunities,” says Partha Chakraborty, Country Manager for NEB India.
“We are excited to bring this level of support to our customers, and to help accelerate their research. The recent addition of several operations, technical support, sales, and marketing staff to augment our existing team enhances our capabilities and underscores our commitment to excellence.”
The establishment of the India subsidiary also aligns with New England Biolabs’ strategy to expand its global footprint while enabling closer engagement with local research institutions, biotechnology companies, and industry stakeholders.
New England Biolabs: Strengthening Engagement with Indian Researchers and Institutions
Commenting on the development, Carole Keating, Executive Director of International Business at NEB, highlighted the growing importance of India’s life science sector.
“It is exciting to see the continued growth of India’s life science industry, which is a testament to the country’s commitment to establishing the groundwork for new technologies and advancements,” stated Carole Keating.
“This expansion of our subsidiary network in India enables NEB to offer even greater personalized service to our customers, rapid delivery, and the ability to explore higher levels of collaboration.”
With the launch of New England Biolabs India Pvt. Ltd., the company aims to further strengthen its engagement with Indian researchers and institutions by offering faster product access, localized technical support, and opportunities for scientific collaboration.
Globally, New England Biolabs maintains subsidiary offices across several regions, including Australia, Canada, China, France, Germany, Japan, New Zealand, Singapore, South Korea, and the United Kingdom.
The addition of the India office marks another strategic step in New England Biolabs’ efforts to support the global life science research community.
